Publications

75.Valle S., Alcalá S., Martin-Hijano L., Cabezas-Sainz P., Navarro D., Ramos Muñoz E., Yuste L., Tiwary K., Walter K., Alonso-Nocelo M., Rubiolo J.A., González-Arnay E., Garcia-Bermejo L., Hermann P.C., Sánchez L., Sancho P., Fernández-Moreno M.A., Sainz B. Jr.
Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
Nat Commun. 2020 Oct 16; 11:5265
PMID: pending
IF 2019: 12.121
Q1 D1
74.Alcalá S, Mayoral-Varo V, Ruiz-Cañas L, López-Gil JC, Heeschen C, Martín-Pérez J, Sainz B Jr.
Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells.
Int J Mol Sci. 2020 Oct 9;21(20):E7437.
PMID: 33050159
IF 2019: 4.556
Q1
73.Gout J, Perkhofer L, Morawe M, Arnold F, Ihle M, Biber S, Lange S, Roger E, Kraus JM, Stifter K, Hahn SA, Zamperone A, Engleitner T, Müller M, Walter K, Rodriguez-Aznar E, Sainz B Jr, Hermann PC, Hessmann E, Müller S, Azoitei N, Lechel A, Liebau S, Wagner M, Simeone DM, Kestler HA, Seufferlein T, Wiesmüller L, Rad R, Frappart PO, Kleger A.
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.
Gut. 2020 Sep 1:gutjnl-2019-319970. doi: 10.1136/gutjnl-2019-319970. Online ahead of print.
PMID: 32873698
IF 2019: 19.819
Q1 D1
72.Cabezas-Sáinz P, Pensado-López A, Sáinz B Jr, Sánchez L.
Modeling Cancer Using Zebrafish Xenografts: Drawbacks for Mimicking the Human Microenvironment.
Cells. 2020 Aug 27;9(9):E1978.
PMID: 32867288
IF 2019: 4.366
Q2
71.Pajuelo-Lozano N, Alcalá S, Sainz B Jr*, Perona R*, Sanchez-Perez I*. (* corresponding)
Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines.
Theranostics. 2020 Jul 25;10(21):9601-9618.
PMID: 32863948
IF 2019: 8.579
Q1 D1
70.Cash TP, Alcalá S, Rico-Ferreira MDR, Hernández-Encinas E, García J, Albarrán MI, Valle S, Muñoz J, Martínez-González S, Blanco-Aparicio C, Pastor J, Serrano M, Sainz B Jr.
Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells.
Cancers (Basel). 2020 Jul 4;12(7):E1790.
PMID: 32635473
IF 2019: 6.126
Q1
69.Alcalá S, Sancho P, Martinelli P, Navarro D, Pedrero C, Martín-Hijano L, Valle S, Earl J, Rodríguez-Serrano M, Ruiz-Cañas L, Rojas K, Carrato A, García-Bermejo L, Fernández-Moreno MÁ, Hermann PC, Sainz B Jr.
ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity.
Nat Commun. 2020 May 29;11(1):2682.
PMID: 32472071
IF 2019: 12.121
Q1 D1
68.Martin-Hijano L, Sainz B Jr.
The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway.
Front Immunol. 2020 Mar 31;11:526.
PMID: 32296435
IF 2019: 5.085
Q1
67.Frappart PO, Walter K, Gout J, Beutel AK, Morawe M, Arnold F, Breunig M, Barth TF, Marienfeld R, Schulte L, Ettrich T, Hackert T, Svinarenko M, Rösler R, Wiese S, Wiese H, Perkhofer L, Müller M, Lechel A, Sainz B Jr, Hermann PC, Seufferlein T, Kleger A.
Pancreatic cancer-derived organoids – a disease modeling tool to predict drug response.
United European Gastroenterol J. 2020 Jun;8(5):594-606.
PMID: 32213029
IF 2019: 3.549
Q2
66.Schulte LA, López-Gil JC, Sainz B Jr, Hermann PC.
The Cancer Stem Cell in Hepatocellular Carcinoma.
Cancers (Basel). 2020 Mar 14;12(3):684.
PMID: 32183251
IF 2019: 6.126
Q1
65.Lerma L, Muñoz AL, García Utrilla R, Sainz B Jr, Lim F, Tabarés E, Gómez-Sebastián S.
Partial complementation between the immediate early proteins ICP4 of herpes simplex virus type 1 and IE180 of pseudorabies virus.
Virus Res. 2020 Apr 2;279:197896.
PMID: 32045631
IF 2019: 2.934
Q2
64.Rodriguez-Aznar E, Wiesmüller L, Sainz B Jr, Hermann PC.
EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells.
Cancers (Basel). 2019 Aug 8;11(8):1136.
PMID: 31398893
IF: 6.126
Q1
63.Walter K, Tiwary K, Trajkovic-Arsic M, Hidalgo-Sastre A, Dierichs L, Liffers ST, Gu J, Gout J, Schulte LA, Münch J, Seufferlein T, Sainz B Jr, Siveke JT, Rodriguez-Aznar E, Hermann PC.
MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo.
Stem Cells Int. 2019 Jun 2;2019:8475389.
PMID: 31281387
IF: 3.869
Q3
62.Alcalá S, Martinelli P, Hermann PC, Heeschen C, Sainz B Jr.
The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures.
Stem Cells Int. 2019 May 2;2019:1378639.
PMID: 31191663
IF: 3.869
Q2
61.Blasco MT, Navas C, Martín-Serrano G, Graña-Castro O, Lechuga CG, Martín-Díaz L, Djurec M, Li J, Morales-Cacho L, Esteban-Burgos L, Perales-Patón J, Bousquet-Mur E, Castellano E, Jacob HKC, Cabras L, Musteanu M, Drosten M, Ortega S, Mulero F, Sainz B Jr, Dusetti N, Iovanna J, Sánchez-Bueno F, Hidalgo M, Khiabanian H, Rabadán R, Al-Shahrour F, Guerra C, Barbacid M.
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.
Cancer Cell. 2019 Apr 15;35(4):573-587.e6.
PMID: 30975481
IF: 26.602
Q1 D1
60.D'Errico G, Alonso-Nocelo M, Vallespinos M, Hermann PC, Alcalá S, García CP, Martin-Hijano L, Valle S, Earl J, Cassiano C, Lombardia L, Feliu J, Monti MC, Seufferlein T, García-Bermejo L, Martinelli P, Carrato A, Sainz B Jr.
Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance.
Oncogene. 2019 Jul;38(27):5469-5485.
PMID: 30936462
IF: 7.971
Q1 D1
59.Alcalá S, Sainz B Jr.
The dark side of radiotherapy-induced cell death in cancer.
EBioMedicine. 2019 Feb;40:7-8.
PMID: 30704926
IF: 5.736
Q1
58.González I, Earl J, Fernández LJ, Sainz B, Pinto A, Monge R, Alcalá S, Castillejo A, Soto JL, Carrato A.
A Label Free Disposable Device for Rapid Isolation of Rare Tumor Cells from Blood by Ultrasounds.
Micromachines (Basel). 2018 Mar 15;9(3):129.
PMID: 30424062
IF: 2.426
Q2
57.Görgülü K, Diakopoulos KN, Ai J, Schoeps B, Kabacaoglu D, Karpathaki AF, Ciecielski KJ, Kaya-Aksoy E, Ruess DA, Berninger A, Kowalska M, Stevanovic M, Wörmann SM, Wartmann T, Zhao Y, Halangk W, Voronina S, Tepikin A, Schlitter AM, Steiger K, Artati A, Adamski J, Aichler M, Walch A, Jastroch M, Hartleben G, Mantzoros CS, Weichert W, Schmid RM, Herzig S, Krüger A, Sainz B Jr, Lesina M, Algül H.
Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice.
Gastroenterology. 2019 Jan;156(1):203-217.e20.
PMID: 30296435
IF: 17.373
Q1 D1
56.Friederich MW, Timal S, Powell CA, Dallabona C, Kurolap A, Palacios-Zambrano S, Bratkovic D, Derks TGJ, Bick D, Bouman K, Chatfield KC, Damouny-Naoum N, Dishop MK, Falik-Zaccai TC, Fares F, Fedida A, Ferrero I, Gallagher RC, Garesse R, Gilberti M, González C, Gowan K, Habib C, Halligan RK, Kalfon L, Knight K, Lefeber D, Mamblona L, Mandel H, Mory A, Ottoson J, Paperna T, Pruijn GJM, Rebelo-Guiomar PF, Saada A, Sainz B Jr, Salvemini H, Schoots MH, Smeitink JA, Szukszto MJ, Ter Horst HJ, van den Brandt F, van Spronsen FJ, Veltman JA, Wartchow E, Wintjes LT, Zohar Y, Fernández-Moreno MA, Baris HN, Donnini C, Minczuk M, Rodenburg RJ, Van Hove JLK.
Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.
Nat Commun. 2018 Oct 3;9(1):4065.
PMID: 30283131
IF: 11.878
Q1 D1
55.Hermann PC, Sainz B Jr.
Pancreatic cancer stem cells: A state or an entity?
Semin Cancer Biol. 2018 Dec;53:223-231.
PMID: 30130664
IF: 9.658
Q1 D1
54.Zagorac S, Garcia-Bermejo L, Sainz B Jr
The Epigenetic Landscape of Pancreatic Cancer Stem Cells.
Epigenomes 2018, 2(2), 10
n/a
53.Ruess DA, Heynen GJ, Ciecielski KJ, Ai J, Berninger A, Kabacaoglu D, Görgülü K, Dantes Z, Wörmann SM, Diakopoulos KN, Karpathaki AF, Kowalska M, Kaya-Aksoy E, Song L, van der Laan EAZ, López-Alberca MP, Nazaré M, Reichert M, Saur D, Erkan MM, Hopt UT, Sainz B Jr, Birchmeier W, Schmid RM, Lesina M, Algül H.
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase.
Nat Med. 2018 Jul;24(7):954-960.
PMID: 29808009
IF: 30.641
Q1 D1
52.Alguacil-Núñez C, Ferrer-Ortiz I, García-Verdú E, López-Pirez P, Llorente-Cortijo IM, Sainz B Jr.
Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts.
Crit Rev Oncol Hematol. 2018 May;125:102-110.
PMID: 29650269
IF: 5.012
Q1
51.Djurec M, Graña O, Lee A, Troulé K, Espinet E, Cabras L, Navas C, Blasco MT, Martín-Díaz L, Burdiel M, Li J, Liu Z, Vallespinós M, Sanchez-Bueno F, Sprick MR, Trumpp A, Sainz B Jr, Al-Shahrour F, Rabadan R, Guerra C, Barbacid M.
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1147-E1156.
PMID: 29351990
IF: 9.580
Q1 D1
50.Valle S, Martin-Hijano L, Alcalá S, Alonso-Nocelo M, Sainz B Jr.
The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.
Cancers (Basel). 2018 Jan 26;10(2):33.
PMID: 29373514
IF: 6.161
Q1
49.D'Errico G, Machado HL, Sainz B Jr.
A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet.
Clin Transl Med. 2017 Dec;6(1):3.
PMID: 28050779
0.700
48.Martinelli P, Carrillo-de Santa Pau E, Cox T, Sainz B Jr, Dusetti N, Greenhalf W, Rinaldi L, Costello E, Ghaneh P, Malats N, Büchler M, Pajic M, Biankin AV, Iovanna J, Neoptolemos J, Real FX.
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.
Gut. 2017 Sep;66(9):1665-1676.
PMID: 27325420
IF: 16.658
Q1 D1
47.da Silva IL, Montero-Montero L, Martín-Villar E, Martin-Pérez J, Sainz B, Renart J, Toscano Simões R, Soares Veloso É, Salviano Teixeira C, de Oliveira MC, Ferreira E, Quintanilla M.
Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells.
Sci Rep. 2017 Jul 24;7(1):6276.
PMID: 28740236
IF: 4.122
Q1
46.Hohwieler M, Illing A, Hermann PC, Mayer T, Stockmann M, Perkhofer L, Eiseler T, Antony JS, Müller M, Renz S, Kuo CC, Lin Q, Sendler M, Breunig M, Kleiderman SM, Lechel A, Zenker M, Leichsenring M, Rosendahl J, Zenke M, Sainz B Jr, Mayerle J, Costa IG, Seufferlein T, Kormann M, Wagner M, Liebau S, Kleger A.
Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling.
Gut. 2017 Mar;66(3):473-486.
PMID: 27633923
IF: 16.658
Q1 D1
45.Hann A, Sainz B Jr, Hermann PC
The metastatic niche in the liver: tilling the soil for pancreatic cancer progression.
Translational Cancer Research. Feb 2017, 6 (1), S217-S220.
PMID: 12244
n/a
44.López-Gómez M, Casado E, Muñoz M, Alcalá S, Moreno-Rubio J, D'Errico G, Jiménez-Gordo AM, Salinas S, Sainz B Jr.
Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives.
Crit Rev Oncol Hematol. 2016 Nov;107:54-71.
PMID: 27823652
IF: 4.971
Q1
43.Zagorac S, Alcala S, Fernandez Bayon G, Bou Kheir T, Schoenhals M, González-Neira A, Fernandez Fraga M, Aicher A, Heeschen C, Sainz B Jr.
DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster.
Cancer Res. 2016 Aug 1;76(15):4546-58.
PMID: 27261509
IF: 9.122
Q1 D1
42.Sancho P, Alcala S, Usachov V, Hermann PC, Sainz B Jr.
The ever-changing landscape of pancreatic cancer stem cells.
Pancreatology. 2016 Jul-Aug;16(4):489-96.
PMID: 27161173
IF: 2.580
Q3
41.Sainz B Jr, Carron E, Vallespinós M, Machado HL.
Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies.
Mediators Inflamm. 2016;2016:9012369.
PMID: 26980947
IF: 3.232
Q2
40.Lerma L, Alcalá S, Piñero C, Torres M, Martin B, Lim F, Sainz B Jr, Tabarés E.
Expression of the immediate early IE180 protein under the control of the hTERT and CEA tumor-specific promoters in recombinant pseudorabies viruses: Effects of IE180 protein on promoter activity and apoptosis induction.
Virology. 2016 Jan 15;488:9-19.
PMID: 26590793
IF: 3.353
Q2
39.Sancho P, Burgos-Ramos E, Tavera A, Bou Kheir T, Jagust P, Schoenhals M, Barneda D, Sellers K, Campos-Olivas R, Graña O, Viera CR, Yuneva M, Sainz B Jr, Heeschen C.
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.
Cell Metab. 2015 Oct 6;22(4):590-605.
PMID: 26365176
IF: 17.303
Q1 D1
38.Cioffi M, Trabulo SM, Sanchez-Ripoll Y, Miranda-Lorenzo I, Lonardo E, Dorado J, Reis Vieira C, Ramirez JC, Hidalgo M, Aicher A, Hahn S, Sainz B Jr, Heeschen C.
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
Gut. 2015 Dec;64(12):1936-48.
PMID: 25887381
IF: 14.921
Q1 D1
37.Sainz B Jr*, Alcala S, Garcia E, Sanchez-Ripoll Y, Azevedo MM, Cioffi M, Tatari M, Miranda-Lorenzo I, Hidalgo M, Gomez-Lopez G, Cañamero M, Erkan M, Kleeff J, García-Silva S, Sancho P, Hermann PC, Heeschen C.* (* corresponding)
Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
Gut. 2015 Dec;64(12):1921-35.
PMID: 25841238
IF: 14.921
Q1 D1
36.Sainz B Jr, Miranda-Lorenzo I, Heeschen C.
The fuss over lipofuscin: not all autofluorescence is the same.
Eur J Histochem. 2015 Mar 12;59(1):2512.
PMID: 25820568
IF: 2.421
Q4
35.Sainz B Jr*, Martín B, Tatari M, Heeschen C, Guerra S.* (* corresponding)
ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.
Cancer Res. 2014 Dec 15;74(24):7309-20.
PMID: 25368022
IF: 9.329
Q1 D1
34.Uprichard SL, Sainz B Jr.
Inhibition of hepatitis C entry: too soon to dismiss while many are still being denied treatment.
Gut. 2015 Apr;64(4):690-1.
PMID: 25287483
IF: 14.921
Q1 D1
33.Miranda-Lorenzo I, Dorado J, Lonardo E, Alcala S, Serrano AG, Clausell-Tormos J, Cioffi M, Megias D, Zagorac S, Balic A, Hidalgo M, Erkan M, Kleeff J, Scarpa A, Sainz B Jr*, Heeschen C.* (* corresponding)
Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.
Nat Methods. 2014 Nov;11(11):1161-9.
PMID: 25262208
IF: 32.072
Q1 D1
32.Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L, Guerra C, Barbacid M, Wagner M, Vieira CR, Aicher A, Real FX, Sainz B Jr*, Heeschen C.* (* corresponding)
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Gastroenterology. 2014 Nov;147(5):1119-33.e4.
PMID: 25127677
IF: 16.716
Q1 D1
31.Balic A, Sørensen MD, Trabulo SM, Sainz B Jr, Cioffi M, Vieira CR, Miranda-Lorenzo I, Hidalgo M, Kleeff J, Erkan M, Heeschen C.
Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
Mol Cancer Ther. 2014 Jul;13(7):1758-71.
PMID: 24785258
IF: 5.683
Q1
30.Royo S, Sainz B Jr, Hernández-Jiménez E, Reyburn H, López-Collazo E, Guerra S.
Differential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses.
J Virol. 2014 May;88(10):5511-23.
PMID: 24599993
IF: 4.439
Q1
29.Barretto N, Sainz B Jr, Hussain S, Uprichard SL.
Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread.
J Virol. 2014 May;88(9):5050-61.
PMID: 24554660
IF: 4.439
Q1
28.Hermann PC, Trabulo SM, Sainz B Jr, Balic A, Garcia E, Hahn SA, Vandana M, Sahoo SK, Tunici P, Bakker A, Hidalgo M, Heeschen C.
Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts.
PLoS One. 2013 Jun 18;8(6):e66371.
PMID: 23825539
IF: 3.534
Q1
27.Sainz B Jr, Heeschen C.
Standing out from the crowd: cancer stem cells in hepatocellular carcinoma
Cancer Cell. 2013 Apr 15;23(4):431-3.
PMID: 23597561
IF: 23.893
Q1 D1
26.Yu X, Sainz B Jr, Petukhov PA, Uprichard SL.
Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.
Antimicrob Agents Chemother. 2012 Dec;56(12):6109-20
PMID: 22948883
IF: 4.565
Q1
25.Sainz B Jr, Barretto N, Yu X, Corcoran P, Uprichard SL.
Permissiveness of human hepatoma cell lines for HCV infection.
Virol J. 2012 Jan 24;9:30.
PMID: 22273112
IF: 2.092
Q3
24.Sainz B Jr*, Barretto N, Martin DN, Hiraga N, Imamura M, Hussain S, Marsh KA, Yu X, Chayama K, Alrefai WA, Uprichard SL.* (* corresponding)
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.
Nat Med. 2012 Jan 8;18(2):281-5.
PMID: 22231557
IF: 24.302
Q1 D1
23.Tencate V, Sainz B Jr, Cotler SJ, Uprichard SL.
Potential treatment options and future research to increase hepatitis C virus treatment response rate.
Hepat Med. 2010 Oct;2010(2):125-145.
PMID: 21331152
IF: n/a
22.Sainz B Jr, Barretto N, Uprichard SL.
Hepatitis C virus infection in phenotypically distinct Huh7 cell lines.
PLoS One. 2009 Aug 10;4(8):e6561.
PMID: 19668344
IF: 4.351
Q1
21.Yu X, Sainz B Jr, Uprichard SL.
Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.
Antimicrob Agents Chemother. 2009 Oct;53(10):4311-9.
PMID: 19620334
IF: 4.802
Q1
20.Sainz B Jr, TenCate V, Uprichard SL.
Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection.
Virol J. 2009 Jul 15;6:103.
PMID: 19604376
IF: 2.435
Q3
19.Li L, Oropeza CE, Sainz B Jr, Uprichard SL, Gonzalez FJ, McLachlan A.
Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4alpha.
PLoS One. 2009;4(5):e5489.
PMID: 19424486
IF: 4.351
Q1
18.Dahari H*, Sainz B Jr*, Perelson AS, Uprichard SL. (*co-first)
Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon.
J Virol. 2009 Jul;83(13):6383-90.
PMID: 19369346
IF: 5.150
Q1
17.Choi S, Sainz B Jr, Corcoran P, Uprichard S, Jeong H.
Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells.
Xenobiotica. 2009 Mar;39(3):205-17.
PMID: 19280519
IF: 2.799
Q2
16.Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr.
Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.
J Clin Endocrinol Metab. 2008 Sep;93(9):3389-95.
PMID: 18492754
IF: 6.325
Q1
15.Colmegna I, Sainz B Jr, Citera G, Maldonado-Cocco JA, Garry RF, Espinoza LR.
Anti-20S proteasome antibodies in psoriatic arthritis.
J Rheumatol. 2008 Apr;35(4):674-6.
PMID: 18278835
IF: 3.282
Q2
14.Mossel EC, Sainz B Jr, Garry RF, Peters CJ.
Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN.
Adv Exp Med Biol. 2006;581:503-6.
PMID: 17037585
IF: 0.646
13.Sainz B Jr, Chisari FV.
Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells.
J Virol. 2006 Oct;80(20):10253-7.
PMID: 17005703
IF: 5.341
Q1
12.Sainz B Jr*, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF. (* corresponding)
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.
Virus Res. 2006 Sep;120(1-2):146-55.
PMID: 16616792
IF: 2.562
Q3
11.Colmegna I, Sainz B Jr, Garry RF, Espinoza LR.
The proteasome and its implications in rheumatology.
J Rheumatol. 2005 Jul;32(7):1192-8.
PMID: 15996052
IF: 3.010
Q2
10.Sainz B Jr, Rausch JM, Gallaher WR, Garry RF, Wimley WC.
Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein.
J Virol. 2005 Jun;79(11):7195-206.
PMID: 15890958
IF: 5.178
Q1
9.Sainz B Jr, LaMarca HL, Garry RF, Morris CA.
Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma.
Virol J. 2005 Feb 23;2:14.
PMID: 15727684
IF: n/a
8.Sainz B Jr, Rausch JM, Gallaher WR, Garry RF, Wimley WC.
The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry.
Biochemistry. 2005 Jan 25;44(3):947-58.
PMID: 15654751
IF: 3.848
Q2
7.LaMarca HL, Sainz B Jr, Morris CA.
Permissive human cytomegalovirus infection of a first trimester extravillous cytotrophoblast cell line.
Virol J. 2004 Nov 17;1:8.
PMID: 15548334
IF: n/a
6.Sainz B Jr, Mossel EC, Peters CJ, Garry RF.
Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
Virology. 2004 Nov 10;329(1):11-7.
PMID: 15476870
IF: 3.71
Q2
5.Sainz B Jr, Halford WP.
Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.
J Virol. 2002 Nov;76(22):11541-50.
PMID: 12388715
IF: 5.241
Q1 D1
4.Härle P, Sainz B Jr, Carr DJ, Halford WP.
The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
Virology. 2002 Feb 15;293(2):295-304.
PMID: 11886249
IF: 3.363
Q1
3.Loutsch JM, Sainz B Jr, Marquart ME, Zheng X, Kesavan P, Higaki S, Hill JM, Tal-Singer R.
Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
Antimicrob Agents Chemother. 2001 Jul;45(7):2044-53.
PMID: 11408221
IF: 4.562
Q1 D1
2.Sainz B, Loutsch JM, Marquart ME, Hill JM.
Stress-associated immunomodulation and herpes simplex virus infections.
Med Hypotheses. 2001 Mar;56(3):348-56.
PMID: 11359358
IF: 0.745
Q3
1.Zheng X, Marquart ME, Loustch JM, Shah P, Sainz B, Ray A, O'Callaghan RJ, Kaufman HE, Hill JM.
HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2490-7.
PMID: 10509641
IF: 4.858
Q1 D1